Stem cells transplanted into 1st Macular-Degeneration patient

StemCells Inc. (STEM) said it transplanted neural stem cells into its first patient with dry age-related macular degeneration, pushing forward its Phase I/II clinical trial.

View the original article here: StemCells Transplants Stem Cells into 1st Macular-Degeneration Patient – Wall Street Journal

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend